HomeVRTX34 • BVMF
Vertex Pharmaceuticals Inc BDR
R$639.16
Jan 16, 1:02:01 PM GMT-3 · BRL · BVMF · Disclaimer
BR listed securityUS headquartered
Previous close
R$639.16
Year range
R$501.50 - R$748.45
Market cap
108.11B USD
Avg Volume
385.00
CDP Climate Change Score
A-
In the news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
2.77B11.61%
Operating expense
371.80M40.94%
Net income
1.05B0.98%
Net profit margin
37.71-9.55%
Earnings per share
4.387.35%
EBITDA
1.18B4.56%
Effective tax rate
14.60%—
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
6.52B-45.30%
Total assets
22.24B2.37%
Total liabilities
6.61B26.78%
Total equity
15.63B—
Shares outstanding
257.53M—
Price to book
10.54—
Return on assets
13.35%—
Return on capital
17.09%—
Net change in cash
(USD)Sep 2024Y/Y change
Net income
1.05B0.98%
Cash from operations
1.37B7.99%
Cash from investing
-348.00M-195.67%
Cash from financing
-387.50M-134.85%
Net change in cash
657.10M-31.78%
Free cash flow
1.09B18.41%
About
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
Founded
1989
Website
Employees
5,400
Search
Clear search
Close search
Google apps
Main menu